MUMBAI, India, Aug. 24 -- Intellectual Property India has published a patent application (202517016796 A) filed by Windtree Therapeutics, Inc. on February 26, 2025, for Istaroxime And Metabolite Derivatives Thereof For Reducing The Risk Of Acute Myocardial Arrhythmia.
Inventors include Simonson, Steven; and Hsu, Shih-Che.
The application for the patent was published on August 21, 2026, under issue no. 34/2026.
Abstract: Compositions for intravenous infusion of istaroxime or derivatives thereof in human patients suffering from AHF with acute myocardial ischemia and/or an acute myocardial infarction are disclosed. The patient may optionally be in early cardiogenic or cardiogenic shock. Likewise, methods of administering istaroxime or derivatives thereof to individuals exhibiting symptoms of, or having been diagnosed with AHF with acute myocardial ischemia and/or an acute myocardial infarction. In particular-, disclosed herein is a method of reducing the risk of or preventing acute myocardial arrhythmias in an individual being treated for AHF with acute myocardial ischemia and/or acute myocardial infarction by administering to the individual a dosage regimen of istaroxime or CVie 216 by intravenous infusion.
Disclaimer: Curated by HT Syndication.
